Flow Cytometry Market: Current Analysis and Forecast (2021-2027)
Request Sample
Pre-order Enquiry
Request Customization
Check Discounts
Flow Cytometry is an impedance-based technology that is used for cell sorting, counting, and detecting biomarkers in protein engineering. The flow cytometer facilitates the evaluation of physical and chemical characteristics of thousands of particles and is majorly used in the diagnosis of health disorders, such as cancer, HIV AIDS, and Immunological disorders. For instance, in January 2021, Becton, Dickinson and Company, announced advancement in immunology research by enabling researchers to investigate 30 immune markers in a single experiment. Further, the growing technological advancements in flow cytometers are also burgeoning the growth of the flow cytometry industry. In September 2020, Agilent Technologies Inc. launched the Agilent NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels.
Moreover, the increasing cases of cancer and other chronic diseases are adding pace to the growth of the flow cytometry market. According to the Office of Disease Prevention and Health Promotion, more than 25 million people in the United States suffer from asthma and more than 14.8 million adults are diagnosed with COPD, and nearly 12 million people are not yet been diagnosed with respiratory diseases in 2020. Also, as per the American Cancer Society, in 2020, there were approximately 89,500 cancer cases diagnosed and about 9,270 cancer deaths in adolescents and young adults aged between 15 to 39 years in the US in 2019. The covid-19 pandemic has impacted the Flow Cytometry market positively. As the increasing number of researches to find the cure of Covid-19 have increased the demand for flow cytometers among researchers to get accurate results of their experiments. For instance, in September 2020, Cytek Biosciences Inc. supported scientists and researchers worldwide in studying the impact of the Covid-19 virus on human immune systems and positions the company on a path to offering a complete spectral flow cytometry solution to the European market from instruments to reagents.
Thermo Fisher Scientific, Beckman Coulter, Inc., Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Apogee Flow Systems Ltd., and Sony Biotechnology, Inc. are some of the prominent players operating in the flow cytometry market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Product, Reagents and Consumables segment holds the major share”
Based on product, the market is bifurcated into instruments, reagents & consumables, replaceable components, accessories, software, and services. The reagents & consumables segment grabbed the major market in 2020 due to their augmented implementations in diagnostic and research fields. Moreover, the overview of multiplex probes and reagents for precise applications in diagnostics as well as drug discovery is anticipated to increase the growth opportunities of this segment in research laboratories and small peripheral laboratories.
“Amongst Technology, Bead-Based segment is anticipated to grow at the highest CAGR during the analyzed period”
Based on technology, the market is bifurcated into cell-based and bead-based technologies. The bead-based segment ruled the market and accounted for the maximum share in 2020 due to the practical advantages presented by this technology over the cell-based technology (such as ELISA, northern blot, and western blot), comprising its ability to spot multiple analytes, high reproducibility, stability, and speed.
“Amongst Application, Research Application segment holds the major share”
Based on application, the market is bifurcated into research applications, clinical applications, and industrial applications. The research applications segment grabbed the major market in 2020. The highest share of this segment can be attributed to the increasing R&D activities connected to cancer and infectious diseases, including Covid-19.
“Amongst End-users, Hospitals & Clinical Testing Laboratories segment holds the major share”
Based on end-user, the market is bifurcated into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment ruled the market and accounted for the maximum share in 2020 due to the increasing number of research for chronic diseases like cancer, HIV AIDS, Immunological disorders including Covid-19.
“North America signifies one of the largest markets of Ventricular assist devices market”
For a better understanding of the market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World. North America constitutes a major market for flow cytometry and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
Flow Cytometry Market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Moreover, the increasing cases of cancer and other chronic diseases are adding pace to the growth of the flow cytometry market. According to the Office of Disease Prevention and Health Promotion, more than 25 million people in the United States suffer from asthma and more than 14.8 million adults are diagnosed with COPD, and nearly 12 million people are not yet been diagnosed with respiratory diseases in 2020. Also, as per the American Cancer Society, in 2020, there were approximately 89,500 cancer cases diagnosed and about 9,270 cancer deaths in adolescents and young adults aged between 15 to 39 years in the US in 2019. The covid-19 pandemic has impacted the Flow Cytometry market positively. As the increasing number of researches to find the cure of Covid-19 have increased the demand for flow cytometers among researchers to get accurate results of their experiments. For instance, in September 2020, Cytek Biosciences Inc. supported scientists and researchers worldwide in studying the impact of the Covid-19 virus on human immune systems and positions the company on a path to offering a complete spectral flow cytometry solution to the European market from instruments to reagents.
Thermo Fisher Scientific, Beckman Coulter, Inc., Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Apogee Flow Systems Ltd., and Sony Biotechnology, Inc. are some of the prominent players operating in the flow cytometry market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Product, Reagents and Consumables segment holds the major share”
Based on product, the market is bifurcated into instruments, reagents & consumables, replaceable components, accessories, software, and services. The reagents & consumables segment grabbed the major market in 2020 due to their augmented implementations in diagnostic and research fields. Moreover, the overview of multiplex probes and reagents for precise applications in diagnostics as well as drug discovery is anticipated to increase the growth opportunities of this segment in research laboratories and small peripheral laboratories.
“Amongst Technology, Bead-Based segment is anticipated to grow at the highest CAGR during the analyzed period”
Based on technology, the market is bifurcated into cell-based and bead-based technologies. The bead-based segment ruled the market and accounted for the maximum share in 2020 due to the practical advantages presented by this technology over the cell-based technology (such as ELISA, northern blot, and western blot), comprising its ability to spot multiple analytes, high reproducibility, stability, and speed.
“Amongst Application, Research Application segment holds the major share”
Based on application, the market is bifurcated into research applications, clinical applications, and industrial applications. The research applications segment grabbed the major market in 2020. The highest share of this segment can be attributed to the increasing R&D activities connected to cancer and infectious diseases, including Covid-19.
“Amongst End-users, Hospitals & Clinical Testing Laboratories segment holds the major share”
Based on end-user, the market is bifurcated into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment ruled the market and accounted for the maximum share in 2020 due to the increasing number of research for chronic diseases like cancer, HIV AIDS, Immunological disorders including Covid-19.
“North America signifies one of the largest markets of Ventricular assist devices market”
For a better understanding of the market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World. North America constitutes a major market for flow cytometry and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
Flow Cytometry Market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
UMI-18826134
30-Jul-2021
129
30-Jul-2021
129
License
